| |
| | Publications and other Academic Info : Mark Michael Zalupski, M.D. |
 | | A phase II study using autologous tumor cell/dendritic cell vaccine is also available. |
 | | Leu, K.M., Ostruszka, L.J., Shewach, D., Zalupski, M., Sondak, V., Biermann, J.S., Lee, J.S.-L., Couwlier, C., Palazzolo, K., Baker, L.H. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcomas. |
 | | El-Rayes, B.F., Shields, A., Zalupski, M., Heilbrun, L.K., Jain, V., Terry, D., Ferris, A.M., Philip, P.A. A phase II study of carboplatin and paclitaxel in advanced esophageal cancer. |
| www.med.umich.edu /intmed/hemonc/staff/zalupski.htm (811 words) |
|